Mussarat Tasleem

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Structural Basis

Top Venues

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Mussarat Tasleem, Saeed Ullah, Ajmal Khan, Suraj Narayan Mali, Sunil Kumar, Bijo Mathew, Angelo Oneto, Faiqa Noreen, Gaber E Eldesoky, Silvia Schenone, Ahmed Al-Harrasi, Zahid Shafiq
Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors. RSC advances 14 (30) (2024)
Mussarat Tasleem, Saeed Ullah, Ajmal Khan, Suraj Narayan Mali, Sunil Kumar, Bijo Mathew, Angelo Oneto, Faiqa Noreen, Gaber E Eldesoky, Silvia Schenone, Ahmed Al-Harrasi, Zahid Shafiq
Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors. RSC advances 14 (30) (2024)
Mussarat Tasleem, Saeed Ullah, Sobia Ahsan Halim, Ifra Urooj, Nadeem Ahmed, Rabia Munir, Ajmal Khan, Attalla F El-Kott, Parham Taslimi, Sally Negm, Ahmed Al-Harrasi, Zahid Shafiq
Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches. Archiv der Pharmazie (2023)
Rima D Alharthy, Ifra Urooj, Mussarat Tasleem, Muhammad Khalid, Muhammad Adnan Asghar, Shaista Ijaz Khan, Muhammad Ajmal, Nadeem Ahmed, Zahid Shafiq
Synthesis of novel 3-hydroxy-2-naphthoic hydrazones as selective chemosensors for cyanide ions. RSC advances 13 (22) (2023)
Rima D Alharthy, Ifra Urooj, Mussarat Tasleem, Muhammad Khalid, Muhammad Adnan Asghar, Shaista Ijaz Khan, Muhammad Ajmal, Nadeem Ahmed, Zahid Shafiq
Synthesis of novel 3-hydroxy-2-naphthoic hydrazones as selective chemosensors for cyanide ions. RSC advances 13 (22) (2023)
Saira Naseem, Ahmed Temirak, Aqeel Imran, Saquib Jalil, Shamool Fatima, Parham Taslimi, Jamshed Iqbal, Mussarat Tasleem, Muhammad Nawaz Tahir, Zahid Shafiq
Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease. RSC advances 13 (26) (2023)